Cargando…
Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM
L1 cell adhesion molecule (L1CAM) is aberrantly expressed in malignant tumors and plays important roles in tumor progression. Thus, L1CAM could serve as a therapeutic target and anti-L1CAM antibodies may have potential as anticancer agents. However, L1CAM is expressed in neural cells and the druggab...
Autores principales: | Cho, Seulki, Park, Insoo, Kim, Haejung, Jeong, Mun Sik, Lim, Mooney, Lee, Eung Suk, Kim, Jin Hong, Kim, Semi, Hong, Hyo Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037990/ https://www.ncbi.nlm.nih.gov/pubmed/26785809 http://dx.doi.org/10.1080/19420862.2015.1125067 |
Ejemplares similares
-
Stop and go L1CAM
por: LeBrasseur, Nicole
Publicado: (2003) -
Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma
por: Cho, Seulki, et al.
Publicado: (2017) -
Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods
por: Chae, Heesu, et al.
Publicado: (2021) -
The Pleiotropic Role of L1CAM in Tumor Vasculature
por: Angiolini, Francesca, et al.
Publicado: (2017) -
Ankyrin binding mediates L1CAM interactions with static components of the cytoskeleton and inhibits retrograde movement of L1CAM on the cell surface
por: Gil, Orlando D., et al.
Publicado: (2003)